Executive Summary
Phynova Group plc operates as a developer of pharmaceutical drugs mainly derived from medicines applied in clinical use in China to satisfy unmet needs, such as viral diseases, metabolic disease and cancer, in major therapeutic markets.
Company History
Current Events
Business Model
Products/Services
Segments/Customers
Production/Operations
Distribution/Routes to Market
Market & Competition
Market Share
Main Competitors
Competitive Strengths and Weaknesses
Management
Financials
Profit & Loss
Balance sheet
Cashflow
Valuation
Comparable Companies
SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
